Header cover image

Swiss Undiscovered Growth Opportunities

UPDATED Jul 03, 2022

The market has not yet priced in the high-growth prospects for these companies, featuring low PEG ratio (less than 0.5), high future growth outlook and good value on the Snowflake.

2 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
DBANDeutsche Beteiligungs€33.500%0%€465.4m€63.72PE6.1xE63.5%6.5%Diversified Financials
1CGCRISPR TherapeuticsUS$62.733.6%n/aUS$4.9bUS$113.38PE15.9xE56.9%n/aPharmaceuticals & Biotech
Page 1 of 1